Patient Advocacy: The Lily Foundation is leading the fight against mitochondrial disease
FEBS Letters is proud to inaugurate a new article series centering patient advocacy with an interview with the Lily Foundation, a UK charity leading the fight against mitochondrial disease.
We spoke with founder Liz Curtis MBE, Head of Patient Programmes Katie Waller, and Research Manager Maria O'Hanlon, PhD about the Foundation's aims, achievements and activities.
FEBS Letters has a long history of publishing new findings in mitochondrial biology. We published a Special Issue on mitochondrial disorders in 2021, and two years later opened a Special Section on mitochondrial biology to disseminate and expedite the latest research in this crucial field.
We hope that this article will help bridge the gap between researchers and patients and remind our readers of the human face behind mitochondrial diseases.
FEBS Letters is renowned both for its quality of content and speed of production. Bringing together the most important developments in the molecular biosciences, FEBS Letters provides an international forum for Reviews, Research Letters and Research Articles that merit urgent publication.
Join the FEBS Network today
Joining the FEBS Network’s molecular life sciences community enables you to access special content on the site, present your profile, 'follow' contributors, 'comment' on and 'like' content, post your own content, and set up a tailored email digest for updates.